The new director of US FDA's Office of Generic Drugs believes a few tweaks may be needed to increase assessment process efficiency but does not envision any major changes.
Sally Choe, who took over following Kathleen 'Cook' Uhl's March 1 retirement, said during an interview with the Pink Sheet...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?